XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 59 filers reported holding XENON PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $104,553,128 | -9.4% | 2,681,537 | 0.0% | 0.02% | -10.5% |
| Q1 2024 | $115,440,168 | -6.5% | 2,681,537 | 0.0% | 0.02% | -13.6% |
| Q4 2023 | $123,511,594 | +58.9% | 2,681,537 | +17.9% | 0.02% | +46.7% |
| Q3 2023 | $77,713,112 | -11.3% | 2,274,974 | 0.0% | 0.02% | -11.8% |
| Q2 2023 | $87,586,499 | +7.6% | 2,274,974 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $81,421,319 | -9.2% | 2,274,974 | 0.0% | 0.02% | -10.5% |
| Q4 2022 | $89,702,225 | +9.2% | 2,274,974 | 0.0% | 0.02% | +5.6% |
| Q3 2022 | $82,127,000 | +18.7% | 2,274,974 | 0.0% | 0.02% | +20.0% |
| Q2 2022 | $69,205,000 | -0.5% | 2,274,974 | 0.0% | 0.02% | +25.0% |
| Q1 2022 | $69,546,000 | -2.1% | 2,274,974 | 0.0% | 0.01% | +9.1% |
| Q4 2021 | $71,070,000 | +382.7% | 2,274,974 | +136.1% | 0.01% | +266.7% |
| Q3 2021 | $14,722,000 | -17.9% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $17,940,000 | +4.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,247,000 | +16.4% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $14,819,000 | +38.9% | 963,500 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $10,666,000 | -11.7% | 963,500 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $12,082,000 | +10.6% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $10,926,000 | -13.5% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $12,631,000 | +45.5% | 963,500 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $8,681,000 | -8.6% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $9,500,000 | -3.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,789,000 | +61.0% | 963,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $6,080,000 | -52.2% | 963,500 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $12,718,000 | -3.3% | 963,500 | -32.6% | 0.00% | 0.0% |
| Q2 2018 | $13,147,000 | +87.8% | 1,429,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $7,002,000 | +73.4% | 1,429,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $4,037,000 | -4.2% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $4,216,000 | -6.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $4,501,000 | -21.3% | 1,429,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,716,000 | -39.4% | 1,429,000 | +16.7% | 0.00% | -50.0% |
| Q4 2016 | $9,433,000 | +13.1% | 1,225,000 | +18.9% | 0.00% | 0.0% |
| Q3 2016 | $8,343,000 | +36.8% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $6,098,000 | -15.3% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,200,000 | -13.1% | 1,030,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $8,281,000 | -2.7% | 1,030,000 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $8,508,000 | +11.9% | 1,030,000 | +56.2% | 0.00% | +50.0% |
| Q2 2015 | $7,604,000 | -31.6% | 659,497 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $11,122,000 | -5.2% | 659,497 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $11,732,000 | – | 659,497 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
| Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
| Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
| First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
| Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
| Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
| TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
| BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
| BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |